METHODS
We conducted a nationwide, population-based, historical cohort study of 1,521,501 Israeli adolescents who were examined before compulsory military service in 1967 through 1997; data were linked to the Israeli ESRD registry. Kidney diseases in childhood included congenital anomalies of the kidney and urinary tract, pyelonephritis, and glomerular disease; all participants included in the primary analysis had normal renal function and no hypertension in adolescence. Cox proportionalhazards models were used to estimate the hazard ratio for ESRD associated with a history of childhood kidney disease.
RESULTS
During 30 years of follow-up, ESRD developed in 2490 persons. A history of any childhood kidney disease was associated with a hazard ratio for ESRD of 4.19 (95% confidence interval [CI], 3.52 to 4.99). The associations between each diagnosis of kidney disease in childhood (congenital anomalies of the kidney and urinary tract, pyelonephritis, and glomerular disease) and the risk of ESRD in adulthood were similar in magnitude (multivariable-adjusted hazard ratios of 5.19 [95% CI, 3.41 to 7 .90], 4.03 [95% CI, 3.16 to 5.14], and 3.85 [95% CI, 2.77 to 5 .36], respectively). A history of kidney disease in childhood was associated with younger age at the onset of ESRD (hazard ratio for ESRD among adults <40 years of age, 10.40 [95% CI, 7.96 to 13 .59]).
CONCLUSIONS
A history of clinically evident kidney disease in childhood, even if renal function was apparently normal in adolescence, was associated with a significantly increased risk of ESRD, which suggests that kidney injury or structural abnormality in childhood has long-term consequences.
A BS TR AC T

History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease
Childhood Kidney Disease and Risk of Adult ESRD C hronic kidney disease and endstage renal disease (ESRD) are global health problems with increasing prevalence. 1 Early identification of persons at increased risk may allow for early interventions that might reduce the incidence of progressive chronic kidney disease and its associated complications.
World Kidney Day 2016 focused on childhood kidney disease as a source of chronic kidney disease in childhood and as a precursor to disease in adulthood. 2 Congenital anomalies of the kidney and urinary tract and glomerular disease are the most common diagnoses of kidney disease in childhood; the incidence of congenital anomalies of the kidney and urinary tract during the past decade has been estimated to be 0.4 to 4.0 cases per 1000 births, 3, 4 and the incidence of primary glomerular disease among children has been estimated to be 0.1 to 2.0 cases per 100,000 children per year. 5 Although most of these conditions have a favorable prognosis, the possibility of persistent kidney injury and a potentially increased risk of chronic kidney disease in adulthood may be underappreciated. Some case series and cross-sectional studies have addressed the outcomes of childhood kidney diseases, with an emphasis on congenital anomalies of the kidney and urinary tract. [6] [7] [8] [9] The long-term kidney health outcomes of the broader spectrum of childhood kidney diseases remain largely unknown. Therefore, we conducted a nationwide, populationbased historical cohort study among 1,521,501 adolescents who were followed for 30 years to evaluate whether a history of childhood kidney disease with normal renal function in adolescence was associated with a risk of future development of ESRD.
Me thods
Study Participants
We conducted a historical cohort study of Israeli adolescents. Our study included potential army recruits who had a mean age of 17.7 years (range, 16 to 25) at the initial medical assessment. One year before their conscription, all eligible Israeli adolescents receive a medical assessment that includes a review of medical records, an interview, a physical examination, and, when indicated, referral for further assessment. 10 We excluded persons from the primary analysis if they had received any of the following diagnoses that are considered to confer an increased risk of subsequent ESRD: diabetes mellitus, systemic lupus erythematosus, vasculitis or any rheumatic disease, cancer, hypertension, or evidence of impaired renal function from any cause (Fig. 1) . Persons with evidence of impaired renal function from any cause were included in the secondary analysis.
Because military service is compulsory for Jewish Israeli citizens but not mandatory for the majority of non-Jewish Israeli citizens or residents, the study population included only Jewish recruits. 11 The institutional review boards of both the Israel Defense Forces and Sheba Medical Center approved the study and waived the requirement for informed consent on the basis of preserving participants' anonymity.
Clinical Assessment and Diagnosis
All future conscripts are asked to provide copies of all available medical records, and their family physicians are requested to provide a comprehensive health history summary on a structured form. The summary is reviewed by the physicians who perform the primary medical board examination. In addition, at the time of that medical examination, each future conscript undergoes a physical examination that includes anthropometric measurements, measurement of blood pressure and heart rate, and a dipstick urinalysis test. All future conscripts for whom a kidneyrelated diagnosis cannot be ruled out on the basis of the medical record or examination at the time of the medical board assessment are sent for additional tests and referred to a boardcertified nephrologist. All future conscripts with a history of childhood kidney disease are referred to a board-certified nephrologist for confirmation of the diagnosis. The accuracy and completeness of the medical information with respect to each diagnosis of childhood kidney disease, including a diagnosis established by the nephrologist during subsequent medical evaluation, are additionally assessed and verified by a committee of two trained military service physicians. Each diagnosis is assigned a numerical code and recorded in a central database. A total of 445 participants had more than one diagnosis of childhood kidney disease recorded, of whom 3 had all three disease diagnoses recorded. CAKUT denotes congenital anomalies of the kidney and urinary tract, and ESRD end-stage renal disease. normal findings from the physical examination and laboratory tests performed at the medical board examination are not referred for further evaluation. This process is uniform for all future conscripts.
Diagnosis of History of Childhood Kidney Diseases
Diagnoses of childhood kidney diseases were assessed at baseline (the date of the medical board assessment) and were categorized as congenital anomalies of the kidney and urinary tract, pyelonephritis, or glomerular disease. A medical history of congenital anomalies of the kidney and urinary tract included congenital single kidney, unilateral renal hypodysplasia, renal ectopia, horseshoe kidney, hydronephrosis, hydroureter, ureteropelvic junction stenosis, ureterovesical junction stenosis, and other congenital kidney and urinary malformations not otherwise specified. A total of 3198 participants had a medical history of congenital anomalies of the kidney and urinary tract; 1465 of these participants had undergone complete or partial nephrectomy, pyelostomy or pyeloplasty, or ureterostomy or other operations involving the ureters and kidney. A total of 7231 participants with a history of pyelonephritis were included in the study; a history of pyelonephritis was defined as documentation of either a single episode or recurrent episodes of pyelonephritis, with or without evidence of scarring detected on imaging and with or without additional anatomical malformations. A total of 8611 participants with a history of glomerular disease were included in the study; a history of glomerular disease was defined as documentation of glomerulonephritis or the nephrotic syndrome. Participants with a history of pyelonephritis or glomerular disease had to be free of the disease for at least 1 year before enrollment (i.e., had no clinical event of glomerulonephritis or pyelonephritis, as determined from the medical records provided by the participants' primary physicians). A total of 445 participants (2.4%) had more than one condition registered. Conscripts were eligible for inclusion if they had serum creatinine values within the normal range, had no hypertension or proteinuria, and had undergone further evaluation and received confirmation of the diagnosis of childhood kidney disease by a board-certified nephrologist. As noted above, participants who had abnormal renal function, active kidney disease, or unresolved childhood glomerular disease were excluded from the primary analysis.
The Israeli ESRD Registry
The Israeli ESRD database is a national administrative registry maintained by the Ministry of Health. 12 The database contains information on patients who received any form of renal-replacement therapy (i.e., hemodialysis, peritoneal dialysis, or kidney transplantation). All nephrology and dialysis programs and practices in Israel are mandated to report annually to the Ministry of Health on incident and prevalent cases of ESRD and changes in type of treatment. A single primary diagnosis is recorded for each new patient in the ESRD database. 12 The current study cohort was linked to the Israeli ESRD registry through the identification number given to all Israeli citizens at birth or immigration.
Outcome Variables and Follow-up
The onset of ESRD was defined as the date of initiation of dialysis treatment or the date of renal transplantation, whichever came first. All cases of ESRD from January 1, 1980, to December 31, 2014, were included in the study. The follow-up period extended from the initial assessment by the medical board to the occurrence of ESRD (defined as the initiation of treatment for ESRD) or death or to December 31, 2014, whichever came first. Because cases of ESRD were not registered between 1967 and 1979, data from participants who were enrolled during that period were left-censored in the survival analyses before January 1980.
Statistical Analysis
The study participants were grouped according to whether they had a history of childhood kidney disease (congenital anomalies of the kidney and urinary tract, pyelonephritis, glomerular disease, or any such history) or no history of childhood kidney disease. Incidence rates of ESRD were calculated as the number of ESRD cases divided by the total number of person-years in each childhood kidney disease diagnosis group and in all diagnosis groups combined. Life tables were constructed and plotted to show the incidence of ESRD from any cause among conscripts with a history of childhood kidney disease as compared with conscripts without such a history.
T h e ne w e ngl a nd jou r na l o f m e dicine
In addition, we constructed life tables that included three categories -no history of childhood kidney disease (1,502,909 participants), a history of mild or resolved childhood kidney disease (18,592 participants in all diagnosis groups combined), and a history of childhood kidney disease and documented kidney injury at enrollment (1230 participants). Cox proportional-hazards models were used to estimate the hazard ratios for ESRD in each childhood kidney disease diagnosis group, as well as for all categories combined (history of any mild or resolved disease), as compared with the group with no such history. We determined the unadjusted associations and then used models that controlled for age at study enrollment and sex. Additional models were adjusted for the father's place of birth (categorized as Europe or the Americas, North Africa, West Asia, or Israel), period of enrollment (1967 to 1979, 1980 to 1989, or 1990 to 1997), body-mass index (<25, 25 to 29, or ≥30, calculated as the weight in kilograms divided by the square of the height in meters), and systolic blood pressure (<95th percentile or ≥95th percentile). Multiple imputations for missing data were made with the use of SAS Enterprise Miner software, version 14.1 (SAS Institute).
We performed sensitivity analyses that excluded participants with documentation of microscopic hematuria; that controlled for hematuria; that controlled for other urologic conditions; that stratified participants according to sex, number of childhood diagnoses, period of enrollment, duration of follow-up, and exemption from either military service or high-intensity military service; and that restricted follow-up according to age at enrollment and at the end of follow-up. In addition, in a separate analysis, we investigated possible interactions between the diagnoses that were excluded from the primary analysis (noted above) and a history of childhood kidney disease associated with the risk of ESRD (see the Supplementary Appendix, available with the full text of this article at NEJM.org). Analyses were simultaneously corrected for multiple comparisons with the use of Bonferroni correction, and all confidence intervals were adjusted accordingly.
The proportional-hazards assumption was tested graphically with the use of log-minus-log plots. All statistical analyses were conducted with SPSS software, version 22 (IBM). Table 1 shows the characteristics of the study population, with stratification according to history of childhood kidney disease, by diagnosis group, or no history of childhood kidney disease. During 46,188,970 person-years of followup (mean duration of follow-up, 30.4 years), ESRD developed in 2490 participants, yielding an incidence rate of 5.39 cases per 100,000 personyears. Table 2 shows the characteristics of the participants in whom ESRD developed during the study period, with stratification according to history or no history of childhood kidney disease. Participants with a history of childhood kidney disease were younger at the onset of ESRD than those with no such history (mean [±SD] age, 41.6±10.7 vs. 48.6±10.0 years; P<0.001) and had a shorter follow-up period. Among the participants in whom ESRD developed, the rate of ESRD caused by diabetic nephropathy was lower among those with a history of kidney disease in childhood or adolescence than among those with no such history (14.3% vs. 35.4%, P<0.001). Overall, among the 18,592 participants who had a history of childhood kidney disease, ESRD developed in 140. In an analysis that controlled for sex, age at enrollment, father's place of birth, period of enrollment, body-mass index, and blood pressure, the hazard ratio for ESRD among participants with a history of childhood kidney disease was 4.19 (95% confidence interval [CI], 3.52 to 4.99) ( Table 3) . Figure 2 shows the incidence of ESRD during the follow-up period among the participants with a history of childhood kidney disease (according to recorded diagnosis) as compared with the participants with no history of childhood kidney disease. Among 1,521,501 participants, a total of 3198 (0.2%) had a history of congenital anomalies of the kidney and urinary tract. ESRD developed in 26 participants with such history (0.8%), yielding an incidence rate of 27.6 cases per 100,000 person-years and an unadjusted hazard ratio of 6.07 (95% CI, 4.04 to 9.12) in the comparison with persons with no history of kidney disease. In an analysis that controlled for sex, age at enrollment, father's place of birth, period of enrollment, body-mass index, and blood pressure, this association was altered minimally (hazard ratio for ESRD, 5.19; 95% CI, 3.41 to 7.90) ( Table 3) .
R esult s
History of Childhood Kidney Disease and Risk of ESRD
Association According to Diagnosis
Among the 1465 participants with a history of congenital anomalies of the kidney and urinary tract who had undergone a reported surgical intervention and had normal renal function, 540 had undergone either partial or complete nephrectomy. ESRD developed in 7 of these participants (1.3%), yielding an unadjusted hazard ratio of 8.14 (95% CI, 3.88 to 17.07); an adjusted analysis was not performed for this subgroup because of the small numbers.
Among the 7231 participants who had a history (Table 3) .
Sensitivity Analyses
The exclusion of persons with microhematuria did not materially change the association between a history of childhood kidney disease and an in- 
Discussion
In this population-based cohort study, a history of childhood kidney disease, with no clinical or laboratory evidence of compromised glomerular filtration rate in adolescence, was associated with a significantly increased risk of ESRD in adulthood. The associations between each of the specific underlying conditions and the risk of ESRD in adulthood were similar in magnitude and suggested that among the participants who had a history of congenital anomalies of the kidney and urinary tract, pyelonephritis, or glomerular disease in childhood, with no apparent sequelae in adolescence, the risk of ESRD developing during 30 years of follow-up was approximately four times as high as the risk among participants who had no such history. This study has several limitations. First, owing to the nature of our data collection, we do not have precise information on the clinical presentation, the indication for urologic interventions, the histopathological subtype of the childhood kidney diseases, or the exact age of the participants at the time of clinical presentation during childhood. Therefore, we could not perform analyses according to time from diagnosis or according to the severity or subtype of disease in childhood. Still, none of the potential conscripts who were included in the primary analysis had abnormal findings on clinical indexes of kidney injury at the time of the medical evaluation. Second, we cannot exclude the possibility of misclassifications of childhood kidney diseases, because the participants in this study, especially those who were recruited before the 1980s, probably would not have received a prenatal diagnosis and were subjected to a more limited availability of diagnostic tests or procedures. For example, we suspect that in the case of diagnoses of pyelonephritis, which were more prevalent in the conscription cohorts from the 1960s and 1970s than in later cohorts, some clinicians might not have considered underlying, undiagnosed congenital T h e ne w e ngl a nd jou r na l o f m e dicine anomalies of the kidney and urinary tract. Nevertheless, we did not identify any significant difference in the risk of chronic kidney disease across the various causes of childhood kidney disease. Third, the clinical information on baseline creatinine levels was reported as a dichotomous variable (normal or abnormal) in our database. Therefore, we do not have the baseline measures of estimated glomerular filtration rates for the participants. Fourth, our study was limited to Jewish recruits, and although our study population was highly representative of the Jewish male adolescent population, it was less representative of the Israeli Jewish female adolescent population. Fifth, we did not have information about persons who emigrated from Israel. However, for that factor to substantively bias the results, we would have to assume that emigrants who had no medical history of childhood kidney disease were particularly prone to ESRD, which is an unlikely occurrence. Finally, in the current study, we were not able to consider directly the development during the follow-up period of other medical conditions, such as diabetes mellitus that may be associated with an increased risk of ESRD. The strengths of our study include the use of a large, nationwide cohort with detailed data from clinical assessment. During the enrollment period, the study participants underwent an initial medical evaluation that followed standardized and thorough protocols, and all had a long follow-up period and comprehensive documentation of ESRD. The medical assessments of all the study participants during adolescence were performed under similar protocols. All kidneyrelated diagnoses were confirmed by board-certified nephrologists. Therefore, we were able to adhere to consistent inclusion and exclusion criteria and to uniquely study the question of the association between kidney diseases in childhood and the development of ESRD in adulthood prospectively in our cohort.
The prevalence of congenital anomalies of the kidney and urinary tract in our cohort (0.2%) was similar to the rates reported in other studies. 13, 14 Congenital anomalies of the kidney and urinary tract are a leading cause of chronic kidney disease in children 2, [15] [16] [17] and are responsible for 2.2% of the cases of ESRD in adults. 18 Few data are available on renal function in adolescence among persons who have congenital anomalies of the kidney and urinary tract and in whom ESRD develops in adulthood. There is evidence suggesting an increased risk of ESRD among otherwise healthy kidney donors -a finding that is consistent with our results regarding nephrectomy. 19, 20 We found that the risk of ESRD among adolescents with a history of pyelonephritis was nearly four times as high as the risk among those with no history of childhood kidney disease. Many studies have related chronic kidney disease to postinfection renal scarring and vesicoureteral reflux. 21, 22 A 2011 review suggested that concomitant congenital anomalies of the kidney and urinary tract may contribute to poor outcomes among patients with pyelonephritis and emphasized a distinction between primary renal damage that precedes infection and scars related to urinary tract infections. 23 Our current finding of an increased risk of ESRD among adolescents with a history of apparently resolved glomerular disease is consistent with the increased risk of hypertension in adulthood that we found in a subgroup of this population in a previous study. 24 The current study suggests that mild kidney abnormalities or injury in childhood may confer a risk of ESRD in adulthood, even when there is no overt compromise of renal function in adolescence. This finding is consistent with the formulation that low nephron endowment or loss of nephrons can increase susceptibility to chronic kidney disease as a result of the hyperfiltration of residual nephrons. [25] [26] [27] Despite the low absolute incidence of ESRD, the interpretation of our findings should take into account that ESRD is estimated to represent only 0.1 to 2.0% of all patients with chronic kidney disease, which includes earlier stages before ESRD. 1 We used ESRD as a well-delineated end point that is registered in a database in Israel. However, the finding of a possible risk of ESRD associated with childhood kidney diseases implies that there is an even greater, albeit unmeasured, risk of the considerably more prevalent antecedent stages of chronic kidney disease. Overall, our study suggests that childhood kidney diseases are possible risk factors for future ESRD.
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